Pediatric Hospital Medicine Top 10 Articles

Pediatric Hospital MedicineTop 10 Articles

Elena AragonaJamie Librizzi

Objectives

• Summarize important evidence-based literature relating to pediatric hospital medicine

• Appraise key PHM articles as they relate to clinical practice

Apparent Life-Threatening Events

• Patient 1: 5 month old female p/w ALTE– Difficulty catching breath– Face turned red– Lasted ~10 seconds– 15min after feed

• Patient 2: Ex 34 wk 2mo M p/w ALTE– Hx ALTE 2 wks ago– Went limp for ~30

seconds– Not associated with feed

P: In infants presenting with ALTE

I/C: are there any factors

O: that increase risk of subsequent event?

Management of Apparent Life-Threatening Events in Infants: A Systematic Review

• Objective: lit review to determine– Hx and PE features that suggest inc risk of future adverse event and/or

serious dx– What testing is indicated

• Methods: – Pertinent articles identified and critically appraised

• 1970-2011• ALTE in children <24mo

• Results:– 37 studies identified

• 14 investigated history/PE features• 31 evaluated diagnostic testing• All studies observational; none well suited to define w/u or determine

prognosis…

Management of Apparent Life-Threatening Events in Infants: A Systematic Review

• Results:– Features associated with future adverse event

and/or serious underlying diagnosis• Prematurity• Multiple ALTE• Suspected child abuse

– Little evidence to support routine testing of all patients without these risk factors

Meningitis

• ED calls re: 6yo M with fever & headache found to have CSF pleocytosis, would like to admit on IV abx for bacterial meningitis r/o

P: In children presenting pleocytosis

I/C: Is there a clinical score to identify children with high risk for

O: Bacterial Meningitis

Clinical Prediction Rule for Identifying Children with CSF Pleocytosis at Very Low Risk of

Bacterial Meningitis• Objective:

– To validate clinical prediction rule (Bacterial Meningitis Score)• Methods:

– Review records of children with meningitis evaluated in ED of 20 academic medical centers over 4 years• Inclusion: 29d – 19yo with ICD9 diagnosis of meningitis• Exclusion:

– Critical illness, purpura, VP shunt, recent neurosurgery, immunosuppression, other bacterial infection requiring inpt abx, active lyme disease, pts with abx within 72h of LP

• Bacterial meningitis: + CSF culture OR CSF pleocytosis with + BCx OR CSF pleocytosis with + CSF latex agllutination test for bacteria

– N = 2903 (met inclusion criteria, data available)

Clinical Prediction Rule for Identifying Children with CSF Pleocytosis at Very Low Risk of

Bacterial Meningitis• Results:

– 1714 low risk patients• 2 had bacterial meningitis (infants 1-2mo w E

Coli meningitis and UTI; neg UA at presentation)– NPV: 99.9%, (95% CI 99.6%-100%)

– 1189 not low risk• 119 (10%) had bacterial meningitis• >/= 1 risk factor

– Sensitivity 98.3% (95% CI 94.2%-99.8%)– Specificity 61.5% (95% CI 59.7%-63.3%

– Use caution when applying to infants <2mo • In patients >2mo, >/=1 risk factor had

sensitivity 100%• Pts <2mo, >/=1 risk factor had sensitivity

92.3%

Blood Cultures

• 20mo M with L thigh cellulitis– Failed outpt therapy; plan to admit on

clindamycin• Blood culture?

P: In patients with asthma, bronchiolitis, pneumonia, SSTI

I: does obtaining blood culture

C: versus no blood culture

O: affect outcomes?

Do We Need This Blood Culture?Kavita Parikh, Aisha Barber Davis, Padmaja PavuluriHospital Pediatrics 2014; 4; 78DOI: 10.1542/hpeds.2013-0053

Do We Need This Blood Culture?

• Objective:– To assess BCx rates & results for 4 leading

pediatric diagnoses in low-risk patients• Methods: – Retrospective cohort– Review records over 1 y at CNMC• Inclusion: 6mo – 18yo with bronchiolitis, asthma, SSTI,

CAP• Exclusion: complex pts• N = 5159 (1629 inpt, 3530 outpt/ED)

Do We Need This Blood Culture?

• Results:– BCx in 343 pts:

• 21% of inpts, 3% of ED/outpts– 4% in asthma– 15% in bronchiolitis– 36% in pna– 46% in SSTI

– BCx results• Asthma – all neg• Bronchiolitis – all neg• SSTI – 98% neg or contaminant

– 2 MRSA, 1 GAS• CAP – 99% neg or contaminant

– 1 strep pneumo, 1 moraxella

• BCx– Longer LOS in asthma,

bronchiolitis– If + (n=5), no change in

management• Some got rpt BCx though

• ~$100,000 microbiology costs at our institution

SBI Rule Out in Infant

• 3 wk M with fever– Well appearing, labs reassuring– Admitted on IV antibiotics

P: Neonates <1 mo admitted w/fever for IV antibiotics

I: Discharge at 36h

C: Discharge at 48 hour

O: No missed/untreated SBI

Time to Detection of Bacterial Cultures in Infants Aged 0-90 daysRianna C. Evans and Brian FineHospital Pediatrics 2013;3;97DOI: 10.152/hpeds.2012-0025

Time to Detection of Bacterial Cultures in Infants Aged 0-90 days

• Objective: determine if bacterial cultures in infants <90d would grow pathogenic bacteria in <36h

• Methods– Retrospective Chart Review over 3.5y @ single institution– Infants 0 to 90 d evaluated in ED or inpt for SBI– Excluded: indwelling catheters, ‘sick’, rpt cx

• Data Collection– Manual chart review of all blood, urine, CSF cultures

• True + vs. contaminant - Determined based on tx


• CNMC:– BCx: checked q10min, alarm if + gram stain, team

called• First subsequent read at 16-18 hours, then q24h

– CSF cultures• Goal gram stain within 1 hour• First time to check culture: 16-18 hours, then q24h

– Urine cultures• First read at 16-18 hours, then daily

– Can call at night and ask someone to check if still neg


• Results– 2092 blood cultures; 101/115 + blood cultures

included in analysis• 97% true pathogen (n=38) Bcx grew in 36h

– 2283 urine cultures; 192/232 + urine cultures included in analysis• 95% true pathogen (n=111) Ucx grew in 36h

– 1159 csf cultures; all 14+ included in analysis• 86% true pathogen (n=7) CSFcx grew in 36h

UTI Length of Treatment in Infant

• 3mo F with fever found to have UTI– Admitted on Ceftriaxone

P: Infants admitted with UTI

I: Transition to oral antibiotics after 3d

C: versus longer IV therapy

O: Treatment failure

Length of Intravenous Antibiotic Therapy and Treatment Failure in Infants with Urinary Tract InfectionsPatrick W. Brady, Patrick J. Conway and Anthony GoudiePediatrics 2010; 126; 196DOI: 10.1542/peds.2009-2948

Length of IV Abx Therapy in Infants with UTI

• Objective:– To assess short (<=3d) v long (>=4d) IV abx therapy

and treatment failure in infants <6mo admitted with UTI• Treatment failure = readmit within 30d

• Methods: – Retrospective cohort, infants <6mo admitted to 24

children's hospitals over 5y with UTI or pyelo (PHIS)• Excluded kids w complex conditions


• Results: 12,333 kids met inclusion criteria– Male gender, neonatal status, black, Hispanic, non-private

insurance, known bacteremia, GU abnormality – inc likelihood of receiving IV abx


• Results– Treatment failure overall: 1.9%

• 1.6% in short-course, 2.2% in long-course– Ie maybe sicker pts got long iv abxs and more likely to fail

• Outcome by pt characteristic and length of IV abx » ie gender, age by 1month intervals, race, bacteremia, GU

abnormality)– Only GU abnormality and severity of illness associated w

treatment failure

– Multivariate adjustment (addressed confounders ie severity of illness) – no association between treatment group and outcome

Osteomyelitis

• 10y male admitted for fever, L foot pain– MRI confirmed evidence of osteomyelitis– Patient started on Clinda IV

P: In patients with osteomyelitis does

I: Early transition to PO Abx

C: Versus prolonged IV therapy

O: Affect clinical outcomes?

Prolonged Intravenous Therapy Versus Early Transition to Oral Antimicrobial Therapy for Acute Osteomyelitis in ChildrenTheoklis Zaoutis, et al. Pediatrics 2009; 123;636 DOI: 10.15442/peds.2008-0596

Prolonged IV Therapy Versus Early Transition to PO for Osteomyelitis

• Objective: Compare the effectiveness of early transition from IV to PO for acute, uncomplicated osteo

• Methods: Retrospective cohort study (PHIS)– Children aged 2m-17y dx with osteo between 2000-

2005 at 29 free-standing children’s hospitals• Results:– 1o outcome: Tx failure (readmission w/in 6m)– 2o outcome: Readmit w/in 6m for line complication,

adverse drug rxn, C. Diff, agranulocytosis

Prolonged IV Therapy Versus Early Transition to PO for Osteomyelitis

Results: 1021 prolonged IV, 948 PO• Overall readmission rate significantly higher in

prolonged IV group (10% vs 6%, p= 0.017)• 1o outcome– 5% for prolonged IV group; 4% PO group– No significant association btw Tx failure and mode Abx

therapy• 2o outcome– Prolonged IV therapy group more likely to experience Tx-

related complication• 3% readmitted for catheter complications, 1.6% for Abx

complications (vs 0.4% in PO group, p= 0.005)

GERD

• 2m FT male admitted for persistent emesis with feeds associated with back arching, fussiness– Pt growing appropriately– Work-up only reveals reflux

Are there risks associated with empiric acid suppression treatment of infants and children suspected of having GERDErica Y. Chung and Jeremy YardleyHospital Pediatrics 2013;3;16DOI: 10.1542/hpeds.2012-0077

Are there risks associated with acid suppression therapy?

• Objective: Evaluate the potential serious adverse effects associated with acid suppressive meds in the pediatric population

• Methods: PubMed search– Ages 0-18y; placebo-controlled or comparisons

with a nonacid suppression arm• Results: 14 studies included– NICU, PICU, non-critical care

Are there risks associated with acid suppression therapy?

Results• NICU– Increased risk NEC, sepsis/bacteremia

• PICU– Mixed results on VAP

• Non-critical care– Increased rate PNA, LRTI, gastroenteritis– Associated with C. Diff associated disease

Bronchiolitis

• 6wk female admitted with URI symptoms, increased WOB and fever found to be RSV+– Should she be evaluated for SBI?

P: In infants with bronchiolitis

I: Is testing for serious bacterial infection

C: Compared to not testing

O: Indicated?

Risk of serious bacterial infection in young febrile infants with RSV infectionsLevine D, et al. Pediatrics 2004; 113;1728-1734 DOI: 10.1542/peds.113.6.1662

Serious Bacterial Infections in Infants with RSV

• Methods: Multi-center prospective, cross-sectional study (1998-2001)– All febrile infants, aged 0-60d undergoing SBI eval– RSV testing by antigen detection from NP swabs

• Results– 1248 enrolled (22% tested + RSV)– Overall SBI rate 11.4% (0.7% meningitis, 2% bacteremia,

9.1% UTI)– RSV+ infants less likely to have SBI (7% vs 12.5%; RR 0.6)

Table 3. SBI by RSV Status

Serious Bacterial Infections in Infants with RSV

Results: Age-stratified• <28d: Overall rate of SBI did not differ

significantly btw those who were RSV+ and RSV- (10.1% vs 14.2%, RR 0.71, 95% CI 0.35-1.5)

• 29-60d: Overall rate of SBI was 5.5% (no bacteremia or meningitis) with statistically significant difference between RSV+ and RSV- (5.5% vs 11.7%, RR 0.47, 85% CI 0.24-0.91)

HSV

• 20d male presenting with fever and irritability– No maternal history of HSV– Full SBI evaluation initiated– Should HSV and empiric Acyclovir be done?

P: In infants presenting for evaluation

I/C: What history/PE/labs are associated

O: With HSV infection

HSV

• Methods: Retrospective case study of HSV over 22y (1988-2009) period from single institution– Inclusion: infants <60d with final dx HSV

• Results: – 32 cases included (25 confirmed, 7 probable); all

empirically tx w/ Acyclovir– 75% of cases with CNS disease

HSV• Results:– 1.3% empirically treated infants ultimately

diagnosed with HSV– 90% cases in infants <21d– 50% presented w/ non-specific complaints – 53% presented with fever, 13% hypothermia– HSV meningitis: 1/3 had <20 WBC in CSF– Except in disseminated disease, routinely obtained

labs were not distinctive in HSV-infected infants

Pneumonia

• 4yo M admitted with cough, fever, hypoxia and CXR with RML infiltrate– What is the evidence to support the 2011 IDSA

guideline to use Ampicillin as first-line therapy for CAP?

P: In children hospitalized with community-acquired PNA

I: Does treatment with narrow-spectrum Abx (i.e: Ampicillin)

C: Compared to broad spectrum (i.e: 3rd generation cephalosporin)

O: Have better clinical outcomes?

Narrow vs broad spectrum antimicrobial therapy for children hospitalized with PNAWilliams DJ, et al.* Pediatrics 2013; 132;e1141-8 DOI: 10.1542/peds.2013-1614

* Kavita Parikh, CNMC

Narrow vs Broad Spectrum Abx Tx for PNA

• Methods: Retrospective cohort study; 42 children’s hospitals btw 2005-2011 (PHIS)– Included children aged 6m-18y hospitalized >2d– Excluded potentially severe PNA, pts at risk for

healthcare assoc infections, pleural drainage/PICU/mech vent within first 2 days

• Results:– 1o outcome: LOS– 2o outcome: PICU, 14d readmission, costs

Narrow vs Broad Spectrum Abx Tx for PNA

• Results: 15,564 children included– 89.7% broad-spectrum, 10.3% narrow-spectrum

• No significant difference in LOS btw groups (when adjusted for confounders)

• No significant difference in PICU admits, 14d readmissions

• No significant difference in sub-analysis of wheezers• No significant difference on costs (adjusted analysis)

Runners Up…• Biondi et al. Treatment of Mycoplasma Pneumonia: A Systematic Review. Pediatrics, 2014;

113; 1081.

• Starmer et al. Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle (IPASS). JAMA, 2013; 310(21): 2262-2270.

• Mussman et al. Suctioning and Length of Stay in Infants Hospitalized with Bronchiolitis. JAMA Pediatrics, 2013; 167(5): 414-421.

• Fernandes et al. Glucocorticoids for Acute Viral Bronchiolitis in Infants and Young Children. Cochrane Database Syst Rev. 2013; 6: CD004878.

• Salo et al. Childhood Urinary Tract Infections as a Cause of Chronic Kidney Disease. Pediatrics. 2011; 128(5): 840-847.

• Ralston et al. Occult Serious Bacterial Infection in Infants Younger than 60 to 90 Days with Bronchiolitis: a Systemic Review. Arch Pediatr Adolesc Med. 2011; 156(10):951-956.

Next Session: March 2015

• Review Guidelines:– 2006 AAP Bronchiolitis Guidelines– 2011 IDSA PNA Guidelines– 2011 IDSA UTI Guidelines– 2004 AAP Kawasaki Endorsed Clinical Report– 2011 IDSA MRSA Guidelines

Pediatric Hospital Medicine Top 10 Articles

Documents

Transcript of Pediatric Hospital Medicine Top 10 Articles